Drawing for BRANE DISCOVERY

USPTO serial 79045754

BRANE DISCOVERY

Reviewed by CopyMark Law Group

Reg. 3540496Status 404
Filing date
Status date
Registration date
Dec 2, 2008
Examiner
HOFFMAN, DAVID AARON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BRANE DISCOVERY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Analgesic preparations, analgesics, anticonvulsants, antidepressants, antidiabetic preparations, antiemetics, antiparasitics, antiseptic preparations, antiseptics, anti-arthritic compositions, anti-cancer preparations, anti inflammatories, appetite suppressant, burn relief medication, cardiovascular pharmaceuticals, central nervous system stimulants, chemotherapeutics, dermatological pharmaceutical product, gastro-intestinal treatments preparations, glaucoma agents, headache treatment preparations, menstrual symptom treatment preparations, oral analgesics, pain relief medication, parapharmaceutical products for use in dermatology, parasiticides for medical use, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, appetite suppressants, pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of neurodegenerative disorder, septic shock, multiple sclerosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastrointestinal disease; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for use in urology; pharmaceutical products for the treatment of bone disease; pharmaceutical products for the treatment of viral and infectious diseases, and cancer; psychotropics; anti-infectives, pharmaceutical preparation for the relief of pain; topical analgesics; topical anesthetics; tranquilizers; tumor suppressing agentsSECTION 71 - CANCELLED—
042Scientific research within the pharmaceutical fieldSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 30, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Mar 30, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 31, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 25, 2016INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 25, 2016INPCINVALIDATION PROCESSED—
Mar 3, 2016INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 3, 2015C71TCANCELLED SECTION 71—
Apr 17, 2009FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 20, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 20, 2009FIMPFINAL DISPOSITION PROCESSED—
Mar 2, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 2, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 16, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2008NPUBNOTICE OF PUBLICATION—
Aug 14, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 14, 2008ALIEASSIGNED TO LIE—
Aug 7, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2008CNEAEXAMINERS AMENDMENT MAILED—
Jul 23, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Jul 23, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 29, 2007RFNPREFUSAL PROCESSED BY IB—
Dec 10, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 10, 2007RFRRREFUSAL PROCESSED BY MPU—
Dec 8, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 7, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2007DOCKASSIGNED TO EXAMINER—
Nov 30, 2007NWAPNEW APPLICATION ENTERED—
Nov 29, 2007LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Nov 29, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance